UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 383

Sortiert nach

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Annals of oncology, 2012-02, Vol.23 (2), p.406-410

2012

Volltextzugriff (PDF)

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Journal of endocrinological investigation, 2006-04, Vol.29 (4), p.298-302

2006

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Journal of endocrinological investigation, 2006-04, Vol.29 (4), p.298

2006

Volltextzugriff (PDF)

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease

Endocrine-related cancer, 2005-03, Vol.12 (1), p.109-117

2005

Volltextzugriff (PDF)

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Annals of oncology, 2006-05, Vol.17 (suppl-5), p.v118-v122

2006

Volltextzugriff (PDF)

Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

Annals of oncology, 2006-08, Vol.17 (8), p.1336-1337

2006

Volltextzugriff (PDF)

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Annals of oncology, 2011-04, Vol.22 (4), p.988-990

2011

Volltextzugriff (PDF)

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

Annals of oncology, 1999-12, Vol.10 (12), p.1461-1465

1999

Volltextzugriff (PDF)

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

Journal of clinical oncology, 1997-01, Vol.15 (1), p.297-303

1997

Volltextzugriff (PDF)

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease

British journal of cancer, 2005-09, Vol.93 (6), p.633-638

2005

Volltextzugriff (PDF)

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4602-4608

2005

Volltextzugriff (PDF)

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease

Prostate cancer and prostatic diseases, 2009-03, Vol.12 (1), p.94-99

2009

Volltextzugriff (PDF)

Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen

Annals of oncology, 2009-12, Vol.20 (12), p.2019-2020

2009

Volltextzugriff (PDF)

Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis

Osteoporosis international, 2008, Vol.19 (1), p.113-117

2008

Volltextzugriff (PDF)

Nonsurgical correction of nasal deformity in unilateral complete cleft lip : A 6-year follow-up

Plastic and reconstructive surgery (1963), 1999-09, Vol.104 (3), p.616-630

1999

Volltextzugriff (PDF)

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

British journal of cancer, 2001-10, Vol.85 (8), p.1106-1112

2001

Volltextzugriff (PDF)

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases

British journal of cancer, 2008-06, Vol.98 (11), p.1753-1758

2008

Volltextzugriff (PDF)

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Journal of endocrinological investigation, 2005, Vol.28 (11 Suppl International), p.141-145

2005

Volltextzugriff (PDF)

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers

Annals of oncology, 2005-10, Vol.16 (10), p.1662-1666

2005

Volltextzugriff (PDF)

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Annals of oncology, 2012-03, Vol.23 (3), p.695-700

2012

Volltextzugriff (PDF)

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

British journal of cancer, 2005-01, Vol.92 (1), p.24-29

2005

Volltextzugriff (PDF)

Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial

Endocrine-related cancer, 2005-06, Vol.12 (2), p.383-392

2005

Volltextzugriff (PDF)

Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma

Annals of oncology, 2001, Vol.12 (suppl-2), p.S159-S164

2001

Volltextzugriff (PDF)

1 – 25 von 383

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(213)
Science & Technology
(159)
Life Sciences & Biomedicine
(143)
Female
(131)
Middle Aged
(109)
Male
(95)
Biological And Medical Sciences
(93)
Medical Sciences
(90)
Adult
(85)
Aged
(82)
Oncology
(79)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)
Pharmacology. Drug Treatments
(34)
Chemotherapy
(29)
Gynecology. Andrology. Obstetrics
(29)
Tumors
(29)
Old Medline
(28)
Antineoplastic Agents
(26)
Mammary Gland Diseases
(26)
Animals
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease

Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen

Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis

Nonsurgical correction of nasal deformity in unilateral complete cleft lip : A 6-year follow-up

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial

Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma

Aktive Filter

Suchergebnisse filtern